Evidence map›Paper›PMID 34710280›Full record

ArticleInternational journal of clinical practice2021

Effects of COVID-19 pandemic in a breast unit: Is it possible to avoid delays in surgical treatment?

Gamze Kiziltan, Bilge Kagan Cetin Tumer, Onur Can Guler, Cihangir Ozaslan

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Breast cancer care amidst a pandemic: a scoping review to understand the impact of coronavirus disease 2019 on health services and health outcomes.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2023
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Gamze KiziltanDepartment of General Surgery, University of Health Sciences Dr. AY Ankara Oncology Training and Research Hospital, Ankara, Turkey.
Bilge Kagan Cetin TumerDepartment of General Surgery, University of Health Sciences Dr. AY Ankara Oncology Training and Research Hospital, Ankara, Turkey.
Onur Can GulerDepartment of General Surgery, University of Health Sciences Dr. AY Ankara Oncology Training and Research Hospital, Ankara, Turkey.
Cihangir OzaslanDepartment of Surgical Oncology, University of Health Sciences Dr. AY Ankara Oncology Training and Research Hospital, Ankara, Turkey.
Sağlık Bilimleri Üniversitesi · TRMinistry of Health · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) pandemic has caused fear all around the world. With people avoiding hospitals, there has been a significant decrease in outpatient clinics. In this study, we aimed to compare and explore the first peak of the pandemic period by studying its effects on patient applications, new diagnoses and treatment approaches in a non-infected hospital.

methodsWe collected data from the first peak of the pandemic period in Turkey, from the pandemic declaration (11 March 2020) to social normalization (1 June 2020), and compared it with the data from a pre-pandemic period with a similar length of time. We analyzed the data of breast cancer patients from application to surgery.

resultsThe data of 34 577 patients were analyzed for this study. The number of patients who applied to outpatient clinics decreased significantly during the pandemic period. After excluding control patients and benign disorders, a figure was reached for the number of patients who had a new diagnosis of breast cancer (146 vs. 250), were referred to neoadjuvant treatment (18 vs. 34), and were treated with surgery (121 vs. 229). All numbers decreased during the pandemic period, except for surgeries after neoadjuvant treatment (21 vs. 25). Surgical treatment approaches also changed. However, the rate of newly diagnosed breast cancer patients treated with surgery was similar in both periods. None of these patients were diagnosed with COVID-19 or died during the pandemic.

conclusionThis study shows that non-infected hospitals can be useful in avoiding delays in the surgical treatment of cancer patients.

Indexed as

COVID-19Ambulatory Care FacilitiesHospitalsHumansPandemicsSARS-CoV-2

Identifiers

PMID34710280
PMCPMC8646425
OpenAlexW3160931446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.